NCT02448628View on ClinicalTrials.gov

A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment

PHASE2CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Hypertension

Interventions

DRUG

CS-3150

Trial Locations (1)

530-0001

Osaka

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY